ORTEXORTEX News
Tracking BWA? Get live short interest, options flow, and signals on ORTEX.Sign up free →
BW
Earnings PreviewBWA

BWA Options Signal Caution as Shorts Cover Ahead of Q2 Print

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 27 Jul 2026, 04:00

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit
ORTEX chart of BorgWarner Inc. (BWA) share price and short interest (% of free float), three months to July 23, 2026
ORTEX data as of 27 Jul 2026, 04:00

BorgWarner heads into its July 30 Q2 earnings report with options traders markedly more defensive than usual, even as short sellers have been quietly stepping back.

The options market is the clearest signal of pre-earnings anxiety. The put/call ratio has climbed to 0.71, within a whisker of its 52-week high of 0.72, and running well above its 20-day average of 0.59 — a gap of roughly 1.6 standard deviations. That shift happened fast: the PCR was below 0.50 just two weeks ago. Investors have loaded up on downside protection at a pace that stands out even in a stock that has already shed nearly 9% over the past month, closing Friday at $64.39.

Short sellers, by contrast, have been retreating. Short interest has dropped 26% over the past month to roughly 3.1% of the free float — a meaningful unwind from the elevated positioning seen in June, when shorts held closer to 4.7% of float. Borrow conditions confirm there is no squeeze dynamic at play: the cost to borrow has eased to just 0.38%, and availability is extremely loose at over 6,000% — meaning the lending pool is effectively untouched. The divergence is notable: options traders are hedging aggressively while short sellers are reducing exposure, which suggests the hedging is more about earnings event risk than a directional bet against the stock.

The analyst community has generally been moving in BWA's favour since the May print, where the stock gained 1.6% on the day and then rallied almost 17% over the following five sessions. Barclays lifted its target to $83 in early July, maintaining Overweight. UBS made the most dramatic move in June, upgrading from Neutral to Buy and raising its target from $61 to $95. Wells Fargo and JP Morgan also raised targets while holding positive ratings. The mean price target of roughly $77 implies around 19% upside from current levels. The lone cautious voice has been Morgan Stanley, sitting at Equal-Weight with a $67 target — essentially flat to the current price. The bull case centres on BorgWarner's pivot into EV components and cost discipline; bears point to the structural drag of declining combustion-engine volumes and the slower-than-expected pace of electrification across its key customer base.

The February print moved in the opposite direction — the stock fell 5% on the day and another 4% over the following week — a reminder that the reaction function here is not one-sided. The July 30 report will test whether the post-May rally, which has since partially reversed, was pricing in a durable improvement in margins and EV order momentum, or simply a relief trade that has run its course.

Against its own history

This week's change in short interest is 3.7 standard deviations above the company's typical weekly move over the past year.

Against its peers

Shares moved +3.1% over the past week against a median of -0.9% for its closest peers.

Stocks in this article

See the live data behind this article on ORTEX.

Open BWA on ORTEX →

How this article was generated

Generated
27 Jul 2026, 04:04
Data as of
27 Jul 2026, 04:00
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notes

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.